Annual FCF
$752.00 K
+$4.12 M+122.31%
31 December 2023
Summary:
Nephros annual free cash flow is currently $752.00 thousand, with the most recent change of +$4.12 million (+122.31%) on 31 December 2023. During the last 3 years, it has risen by +$7.89 million (+110.53%). NEPH annual FCF is now at all-time high.NEPH Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$623.00 K
-$67.00 K-12.05%
01 September 2024
Summary:
Nephros quarterly free cash flow is currently -$623.00 thousand, with the most recent change of -$67.00 thousand (-12.05%) on 01 September 2024. Over the past year, it has dropped by -$1.19 million (-210.85%). NEPH quarterly FCF is now -134.73% below its all-time high of $1.79 million, reached on 31 December 2017.NEPH Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$2.09 M
-$1.19 M-131.23%
01 September 2024
Summary:
Nephros TTM free cash flow is currently -$2.09 million, with the most recent change of -$1.19 million (-131.23%) on 01 September 2024. Over the past year, it has dropped by -$2.96 million (-340.28%). NEPH TTM FCF is now -340.28% below its all-time high of $869.00 thousand, reached on 30 September 2023.NEPH TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NEPH Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +122.3% | -210.8% | -340.3% |
| 3 y3 years | +110.5% | +32.5% | +21.0% |
| 5 y5 years | +120.5% | +0.8% | +34.4% |
NEPH Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +110.5% | -210.8% | +66.0% | -340.3% | +51.0% |
| 5 y | 5 years | at high | +110.5% | -210.8% | +68.0% | -340.3% | +70.8% |
| alltime | all time | at high | +108.6% | -134.7% | +81.3% | -340.3% | +73.0% |
Nephros Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$623.00 K(+12.1%) | -$2.09 M(+131.2%) |
| June 2024 | - | -$556.00 K(-17.3%) | -$903.00 K(+646.3%) |
| Mar 2024 | - | -$672.00 K(+183.5%) | -$121.00 K(-114.6%) |
| Dec 2023 | $752.00 K(-122.3%) | -$237.00 K(-142.2%) | $827.00 K(-4.8%) |
| Sept 2023 | - | $562.00 K(+148.7%) | $869.00 K(+534.3%) |
| June 2023 | - | $226.00 K(-18.1%) | $137.00 K(-110.8%) |
| Mar 2023 | - | $276.00 K(-241.5%) | -$1.26 M(-62.5%) |
| Dec 2022 | -$3.37 M(+132.0%) | -$195.00 K(+14.7%) | -$3.37 M(-4.0%) |
| Sept 2022 | - | -$170.00 K(-85.5%) | -$3.51 M(-17.7%) |
| June 2022 | - | -$1.18 M(-35.8%) | -$4.26 M(+33.0%) |
| Mar 2022 | - | -$1.83 M(+446.6%) | -$3.21 M(+120.6%) |
| Dec 2021 | -$1.45 M(-79.7%) | -$335.00 K(-63.7%) | -$1.45 M(-45.0%) |
| Sept 2021 | - | -$923.00 K(+688.9%) | -$2.64 M(-25.5%) |
| June 2021 | - | -$117.00 K(+50.0%) | -$3.55 M(-34.0%) |
| Mar 2021 | - | -$78.00 K(-94.9%) | -$5.38 M(-24.7%) |
| Dec 2020 | -$7.14 M(+211.9%) | -$1.53 M(-16.6%) | -$7.14 M(+36.0%) |
| Sept 2020 | - | -$1.83 M(-6.0%) | -$5.25 M(+29.7%) |
| June 2020 | - | -$1.95 M(+5.8%) | -$4.05 M(+18.0%) |
| Mar 2020 | - | -$1.84 M(-605.5%) | -$3.43 M(+49.9%) |
| Dec 2019 | -$2.29 M(-37.5%) | $364.00 K(-158.0%) | -$2.29 M(-28.0%) |
| Sept 2019 | - | -$628.00 K(-52.7%) | -$3.18 M(-13.4%) |
| June 2019 | - | -$1.33 M(+90.7%) | -$3.68 M(-0.4%) |
| Mar 2019 | - | -$697.00 K(+32.0%) | -$3.69 M(+0.8%) |
| Dec 2018 | -$3.66 M(+4655.8%) | -$528.00 K(-52.9%) | -$3.66 M(+173.3%) |
| Sept 2018 | - | -$1.12 M(-16.5%) | -$1.34 M(+43.9%) |
| June 2018 | - | -$1.34 M(+100.7%) | -$931.00 K(+970.1%) |
| Mar 2018 | - | -$669.00 K(-137.3%) | -$87.00 K(+13.0%) |
| Dec 2017 | -$77.00 K(-96.4%) | $1.79 M(-351.6%) | -$77.00 K(-96.8%) |
| Sept 2017 | - | -$713.00 K(+42.9%) | -$2.40 M(-3.3%) |
| June 2017 | - | -$499.00 K(-24.3%) | -$2.48 M(+9.4%) |
| Mar 2017 | - | -$659.00 K(+24.8%) | -$2.27 M(+5.1%) |
| Dec 2016 | -$2.16 M(-43.7%) | -$528.00 K(-33.6%) | -$2.16 M(-24.8%) |
| Sept 2016 | - | -$795.00 K(+178.0%) | -$2.87 M(-10.3%) |
| June 2016 | - | -$286.00 K(-47.8%) | -$3.20 M(-7.2%) |
| Mar 2016 | - | -$548.00 K(-55.8%) | -$3.45 M(-9.7%) |
| Dec 2015 | -$3.83 M(+53.4%) | -$1.24 M(+10.3%) | -$3.81 M(+12.0%) |
| Sept 2015 | - | -$1.12 M(+110.5%) | -$3.41 M(+10.6%) |
| June 2015 | - | -$534.00 K(-41.8%) | -$3.08 M(+10.4%) |
| Mar 2015 | - | -$917.00 K(+10.3%) | -$2.79 M(+11.8%) |
| Dec 2014 | -$2.50 M | -$831.00 K(+4.3%) | -$2.50 M(-2.2%) |
| Sept 2014 | - | -$797.00 K(+225.3%) | -$2.55 M(+34.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2014 | - | -$245.00 K(-60.6%) | -$1.89 M(-42.2%) |
| Mar 2014 | - | -$622.00 K(-29.9%) | -$3.28 M(-8.6%) |
| Dec 2013 | -$3.58 M(+61.8%) | -$887.00 K(+542.8%) | -$3.58 M(+13.6%) |
| Sept 2013 | - | -$138.00 K(-91.5%) | -$3.15 M(-15.5%) |
| June 2013 | - | -$1.63 M(+75.3%) | -$3.73 M(+4.7%) |
| Mar 2013 | - | -$929.00 K(+102.4%) | -$3.57 M(+61.2%) |
| Dec 2012 | -$2.21 M(+70.8%) | -$459.00 K(-36.0%) | -$2.21 M(-6.7%) |
| Sept 2012 | - | -$717.00 K(-51.0%) | -$2.37 M(+90.4%) |
| June 2012 | - | -$1.46 M(-444.2%) | -$1.25 M(+285.8%) |
| Mar 2012 | - | $425.00 K(-168.9%) | -$323.00 K(-75.1%) |
| Dec 2011 | -$1.30 M(-2.0%) | -$617.00 K(-250.9%) | -$1.30 M(-2.6%) |
| Sept 2011 | - | $409.00 K(-175.7%) | -$1.33 M(-19.9%) |
| June 2011 | - | -$540.00 K(-1.5%) | -$1.66 M(+18.1%) |
| Mar 2011 | - | -$548.00 K(-15.8%) | -$1.41 M(+8.8%) |
| Dec 2010 | -$1.32 M(-49.9%) | -$651.00 K(-934.6%) | -$1.29 M(-6.6%) |
| Sept 2010 | - | $78.00 K(-127.4%) | -$1.38 M(-27.2%) |
| June 2010 | - | -$285.00 K(-34.3%) | -$1.90 M(-20.3%) |
| Mar 2010 | - | -$434.00 K(-41.5%) | -$2.39 M(-8.7%) |
| Dec 2009 | -$2.64 M(-54.7%) | -$742.00 K(+68.6%) | -$2.61 M(-20.8%) |
| Sept 2009 | - | -$440.00 K(-42.9%) | -$3.30 M(-28.3%) |
| June 2009 | - | -$770.00 K(+16.7%) | -$4.60 M(-12.0%) |
| Mar 2009 | - | -$660.00 K(-53.8%) | -$5.23 M(-10.1%) |
| Dec 2008 | -$5.82 M(-23.2%) | -$1.43 M(-18.0%) | -$5.82 M(-24.7%) |
| Sept 2008 | - | -$1.74 M(+24.7%) | -$7.73 M(+0.5%) |
| June 2008 | - | -$1.40 M(+12.0%) | -$7.69 M(+8.6%) |
| Mar 2008 | - | -$1.25 M(-62.6%) | -$7.09 M(-6.5%) |
| Dec 2007 | -$7.58 M(+2.3%) | -$3.34 M(+95.8%) | -$7.58 M(+28.0%) |
| Sept 2007 | - | -$1.71 M(+115.4%) | -$5.92 M(-4.3%) |
| June 2007 | - | -$792.00 K(-54.5%) | -$6.19 M(-19.0%) |
| Mar 2007 | - | -$1.74 M(+3.4%) | -$7.64 M(+3.1%) |
| Dec 2006 | -$7.41 M(+34.7%) | -$1.68 M(-14.6%) | -$7.41 M(-0.8%) |
| Sept 2006 | - | -$1.97 M(-12.0%) | -$7.47 M(-0.9%) |
| June 2006 | - | -$2.24 M(+48.1%) | -$7.53 M(+12.6%) |
| Mar 2006 | - | -$1.51 M(-13.1%) | -$6.69 M(+21.7%) |
| Dec 2005 | -$5.50 M(-37.1%) | -$1.74 M(-14.7%) | -$5.50 M(+46.3%) |
| Sept 2005 | - | -$2.04 M(+45.6%) | -$3.76 M(+118.5%) |
| June 2005 | - | -$1.40 M(+337.1%) | -$1.72 M(+437.1%) |
| Mar 2005 | - | -$320.50 K | -$320.50 K |
| Dec 2004 | -$8.74 M(+126.1%) | - | - |
| Dec 2003 | -$3.87 M(+110.4%) | - | - |
| Dec 2002 | -$1.84 M | - | - |
FAQ
- What is Nephros annual free cash flow?
- What is the all time high annual FCF for Nephros?
- What is Nephros annual FCF year-on-year change?
- What is Nephros quarterly free cash flow?
- What is the all time high quarterly FCF for Nephros?
- What is Nephros quarterly FCF year-on-year change?
- What is Nephros TTM free cash flow?
- What is the all time high TTM FCF for Nephros?
- What is Nephros TTM FCF year-on-year change?
What is Nephros annual free cash flow?
The current annual FCF of NEPH is $752.00 K
What is the all time high annual FCF for Nephros?
Nephros all-time high annual free cash flow is $752.00 K
What is Nephros annual FCF year-on-year change?
Over the past year, NEPH annual free cash flow has changed by +$4.12 M (+122.31%)
What is Nephros quarterly free cash flow?
The current quarterly FCF of NEPH is -$623.00 K
What is the all time high quarterly FCF for Nephros?
Nephros all-time high quarterly free cash flow is $1.79 M
What is Nephros quarterly FCF year-on-year change?
Over the past year, NEPH quarterly free cash flow has changed by -$1.19 M (-210.85%)
What is Nephros TTM free cash flow?
The current TTM FCF of NEPH is -$2.09 M
What is the all time high TTM FCF for Nephros?
Nephros all-time high TTM free cash flow is $869.00 K
What is Nephros TTM FCF year-on-year change?
Over the past year, NEPH TTM free cash flow has changed by -$2.96 M (-340.28%)